Pages that link to "Q24804936"
Jump to navigation
Jump to search
The following pages link to A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults (Q24804936):
Displaying 50 items.
- A review of malaria vaccine clinical projects based on the WHO rainbow table (Q21034112) (← links)
- Vaccines for preventing malaria (pre-erythrocytic) (Q24244317) (← links)
- Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination (Q27008256) (← links)
- Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein (Q27973488) (← links)
- Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics (Q27973871) (← links)
- A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya (Q28469062) (← links)
- Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa (Q33284467) (← links)
- Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies (Q33440600) (← links)
- Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data (Q33521372) (← links)
- Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model (Q33587443) (← links)
- Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease (Q33821137) (← links)
- Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens (Q33843258) (← links)
- New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model (Q33868760) (← links)
- A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice (Q33945612) (← links)
- Advances and challenges in malaria vaccine development. (Q34145333) (← links)
- Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes (Q34165879) (← links)
- Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein (Q34182371) (← links)
- Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations (Q34301461) (← links)
- Plasmodium immunomics. (Q34419934) (← links)
- Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized (Q34612788) (← links)
- A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS. (Q34734075) (← links)
- Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths (Q34978256) (← links)
- A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. (Q35073970) (← links)
- Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector (Q35741984) (← links)
- Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F (Q35766685) (← links)
- Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines (Q35862464) (← links)
- A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria (Q35927866) (← links)
- Building better T-cell-inducing malaria vaccines. (Q36122648) (← links)
- Vaccinology at the beginning of the 21st century (Q36159950) (← links)
- Malaria vaccines in development (Q36219634) (← links)
- Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis (Q36252595) (← links)
- Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria (Q36383811) (← links)
- Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults (Q36393102) (← links)
- Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity". (Q36394177) (← links)
- Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques (Q36397581) (← links)
- Pre-erythrocytic malaria vaccines: towards greater efficacy (Q36403400) (← links)
- Tuberculosis vaccines: current status and future prospects (Q36458393) (← links)
- Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination (Q36474557) (← links)
- Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria (Q36538784) (← links)
- A review of human vaccine research and development: malaria (Q36625367) (← links)
- Pre-erythrocytic malaria vaccines: identifying the targets (Q36644236) (← links)
- Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites (Q36702125) (← links)
- High road, low road? Choices and challenges on the pathway to a malaria vaccine (Q36726723) (← links)
- Vaccines against malaria - an update (Q36933780) (← links)
- Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1. (Q37073334) (← links)
- Plasmodium falciparum malaria vaccines in development (Q37103927) (← links)
- Various carrier system(s)- mediated genetic vaccination strategies against malaria (Q37150329) (← links)
- Malaria vaccines: a toy for travelers or a tool for eradication? (Q37194780) (← links)
- Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria (Q37243245) (← links)
- Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area (Q37331599) (← links)